Researchers identify novel regulatory mechanism in inflammatory signaling of immune cells

(PhysOrg.com) -- Using cancer cells that were originally isolated from an anaplastic large cell lymphoma patient, two researchers, including a faculty member of The University of Texas at Austin's College of Pharmacy, have identified a novel regulatory mechanism in inflammatory signaling of immune cells that may prove beneficial in treating cancer.

If you want to include this story in your blog, copy and paste this formatted text: